Investors

Investor Relations

DISCOVERING AND DEVELOPING NOVEL THERAPIES THAT CAN OVERCOME RESISTANCE IN CANCER

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Press
Releases
November 12, 2024

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

November 4, 2024

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Upcoming
Events
Nov 21, 2024 at 7:00 AM EST
Jefferies London Healthcare Conference
INVESTOR
CONTACT

ORIC Pharmaceuticals’ investor relations department can be reached via email at investors@oricpharma.com.

Contact